XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.25.1

COMMON EQUITY (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Equity [Abstract] |
Schedule of stock-based compensation awards granted | During the three months ended March 31, 2025, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:
Award Type |  | Number of Awards
Stock options (1) |  | 231,024 |
Restricted shares (2) |  | 79,170 |
Performance units |  | 185,945 |
(1)Stock options awarded had a weighted-average exercise price of $94.55 and a weighted-average grant date fair value of $18.23 per option. (2)Restricted shares awarded had a weighted-average grant date fair value of $94.55 per share.
Schedule of Common Stock Outstanding Roll Forward | We had the following changes to our outstanding common stock during the three months ended March 31, 2025 and 2024:
|  | Three Months Ended March 31, 2025 |  | Three Months Ended March 31, 2024
Common stock shares outstanding at beginning of period |  | 317,680,855 |  |  | 315,434,531 |
Shares issued: |  |  |  |
At-the-market offering program |  | 977,824 |  |  | — |
Stock-based compensation |  | 342,711 |  |  | 142,178 |
401(k) |  | 43,300 |  |  | 124,300 |
Stock investment plan |  | 88,811 |  |  | 121,578 |
Common stock shares outstanding at end of period |  | 319,133,501 |  |  | 315,822,587 |
Schedule of Earnings Per Share, Basic and Diluted | The following table shows the computation of our basic and diluted EPS for the three months ended March 31, 2025 and 2024:
(in millions) |  | Three Months Ended March 31, 2025 |  | Three Months Ended March 31, 2024
Numerator: |  |  |  |
Net income attributed to common shareholders |  | $ | 724.2 |  |  | $ | 622.3 |
Denominator: |  |  |  |
Weighted average basic shares outstanding |  | 318.2 |  | 315.6
Dilutive effect of stock-based compensation awards |  | 0.5 |  |  | 0.3 |
Dilutive effect of convertible senior notes |  | 0.6 |  |  | — |
Weighted average diluted shares |  | 319.3 |  |  | 315.9 |
Basic EPS |  | $ | 2.28 |  |  | $ | 1.97 |
Diluted EPS |  | $ | 2.27 |  |  | $ | 1.97 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of equity awards granted during the period, including the weighted-average grant-date fair value and the weighted-average exercise price per award. + References No definition available. + Details
Name: | wec_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantedinPeriodTableTextBlock
Namespace Prefix: | wec_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration